IBM has decided to make all three tools open-source, meaning scientists will be able to use them in their research whenever they please, according to ZDNet. The tools are designed to streamline the cancer drug development process and help scientists stay on top of newly-published research — so, if they prove useful, it could mean more cancer treatments coming through the pipeline more rapidly than before.
* PaccMann - uses deep learning algorithms to predict whether compounds will be viable anticancer drugs, taking some of the expensive guesswork out of pharmaceutical development
* INtERAcT - which automatically parses medical journals for important updates in the field
* PIMKL - which helps doctors provide tailor-fit care based on individual patients’ needs
#IBM IBM just made its cancer-fighting AI projects open-source
"Our goal is to deepen our understanding of cancer to equip industries and academia with the knowledge that could potentially one day help fuel new treatments and therapies."